Triage Cardio Profiler/Triage Cardiac Panel
Test, Natriuretic Peptide. 510(k) K030286, from Biosite Incorporated (San Diego, CA). Product code NBC, class 2.
As of Nov 18, 2026, K030286 is an FDA 510(k) held by Biosite Incorporated, substantially equivalent on Feb 21, 2003 after 24 days, with 3 recalls tied to it in FDA's recall database.
- Review time: 24 days
- Recalls: 3
- Cited as a predicate by: 1 device
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFThe Triage® Cardio ProfilER is a fluorescence immunoassay to be used with the Triage® Meter for the quantitative determination of Creatine Kinase MB, myoglobin, troponin I, and B-type natriuretic peptide in EDTA whole blood and plasma specimens.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Triage Cardiac Panel, Triage Troponin-I, Triage Ck-Mb, Triage Myoglobin, Triage Troponin-I and Ck-Mb, Triage Troponin-IK973126 · Biosite Incorporated · Oct 6, 1997
- Triage B-Type Natriuretic Peptide (Bnp) TestK021317 · Biosite Incorporated · Jul 1, 2002
Cited as a predicate
1 later 510(k) summary names this device as a predicate- Bgm Galectin -3K093758 · Bg Medicine, Inc. · Nov 17, 2010
Recalls
Recalls FDA ties to K030286, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record| May 25, 2023 | Z-1974-2023Raw material issue may cause cardiac panel products to have an average of 30% troponin signal reduction across measurement range 0.05 ng/mL to 30 ng/mL, QC testing won't detect anomaly, so an alternate method is… | Open |
| May 22, 2012 | Z-1929-2012Certain lots of the affected products may have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results. These false… | Terminated |
| Apr 27, 2009 | Z-1391-2009The recall was initiated because the use of the affected lot may lead to reporting falsely low values for troponin I and myoglobin, possibly resulting in missed or incorrect diagnosis. | Terminated |
Other NBC clearances
The newest 510(k)s for the same product code; their median review was 257 days; see every NBC device- Access BNP IIK262597 · Beckman Coulter, Inc. · Oct 20, 2026
- Access NT-proBNPK262109 · Beckman Coulter, Inc. · Sep 21, 2026
- Access BNP IIK252169 · Beckman Coulter, Inc. · Mar 24, 2026
- Alere NT-proBNP for Alinity iK253539 · Axis-Shield Diagnostics, Ltd. · Feb 18, 2026
- Alere NT-proBNP for Alinity i Reagent KitK241176 · Axis-Shield Diagnostics, Ltd. · Jan 16, 2025
- Access NT-proBNPK232164 · Beckman Coulter, Inc. · Apr 12, 2024
- ADVIA Centaur® NT-proBNPII (PBNPII)K220265 · Siemens Healthcare Diagnostics, Inc. · Sep 24, 2023
- Elecsys proBNP II, Elecsys proBNP II STATK223637 · Roche Diagnostics · Jul 21, 2023
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Jan 28, 2003
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1117
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files